ω | Cav2.2 inhibitor | MVIIA | CKGKGAKCSRLMYDCCTGSCRSGKC* | Pain (intrathecal; phase IV) |
μ | Nav inhibitor | SIIIA | ZNCCNGGCSSKWCRDHARCC* | Pain (intravenous) |
μO | Nav1.8 inhibitor | MrVIB | ACSKKWEYCIVPIIGFIYCCPGLICGPFVCV | Pain (intrathecal/intravenous) |
δ | Nav enhancer | EVIA | DDCIKOYGFCSLPILKNGLCCSGACVGVCADL* | ? |
κ | Kv inhibitor | PVIIA | CRIONQKCFQHLDDCCSRKCNNRFNKCV | Cardiac reperfusion |
χ | NET inhibitor | Xen2174 | ZGVCCGYKLCHOC | Pain (intrathecal; phase II) |
α | nAChR inhibitor | Vc1.1 | GCCSDPRCNYDHPEIC* | Pain (intravenous)a |
σ | 5HT3 receptor | GVIIIA | GCTRTCGGOKCTGTCTCTNSSKCGCRYNVHPSGBGCGCACS* | ? |
ρ | α1-Adrenoceptor inhibitor | TIA | FNWRCCLIPACRRNHKKFC* | Cardiovascular/BPH |
Conantokin | NMDA-R antagonist | Con-G | GEγγLQγNQγLIRγKSN | Pain/epilepsy (intrathecal)a |
Conopressin | Vasopressin-R agonist | Cono-G | CFIRNCPKG* | Cardiovascular/mood |
Contulakin | Neurotensin-R agonist | Cont-G | ZSEEGGSNAtKKPYIlL | Pain (intrathecal)a |